Hair loss at Ozempic ' Co.: إلى أي مدى ترتفع المخاطرة وفقاً للدراسات

Factual coreconfirmed by several independent voices

Insufficient core: not enough independent confirmations to retain a shared fact.

Reported detailssecondary facts, each attributed to its source

• وكان المعدل 4.24 في المائة للبرازيباتيد و 3.33 في المائة للسيمغلوتيد.

  according to Frankfurter Rundschau +1

• وبالنسبة للمرأة، كانت القيم 5.44 في المائة و 3.63 في المائة على التوالي.

  according to Frankfurter Rundschau +1

Disputedincompatible versions — to verify

No factual contradiction detected between sources.

Framing by sidesame fact, different words — loaded terms highlighted

No notable framing divergence.

Blind spotwhat one side keeps silent

No blind spot detected: every side covers the same facts.

Sources2 sources cross-checked

Images from the sourcesThe photos each outlet chose to illustrate this story — click to open the article.

• Münchner Merkur